跳至主要内容
临床试验/NL-OMON30726
NL-OMON30726招募中不适用

A new design metal stent, SX-Ella stent Esophageal HV, for the prevention of recurrent dysphagia due to migration or tissue overgrowth: a prospective follow-up study - SX-ELLA stent Esophageal HV for the prevention of recurent dysphagia

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • a.Inoperable malignant obstruction of the esophagus or cardia (a tumor is considered inoperable if the patient has local tumor infiltration in neighboring organs, distant metastases, or a poor general health due to serious concomitant disease).
  • b.Recurrent dysphagia after prior radiation with curative or palliative intent for esophageal cancer.
  • c.Signed informed consent.

排除标准

  • a.Evidence of tumor within 2 cm of the upper esophageal sphincter.
  • b.Esophagotracheal or -bronchial fistula or both.
  • c.Lesions longer than 12 cm.
  • d.WHO performance score of 4.
  • e.Lack of fitness for sedation (including known allergies).

研究者

相似试验

A new design metal stent, SX-Ella stent Esophageal... | 临床试验